Anti-NGAL (human, neutrophil gelatinase-associated lipocalin)
Mouse monoclonal antibody, biotinylated
Cat.No. HYB 211-02B
Preparation: Biotinylated
Content: Available in 50 µL, 1 mg/mL
Solvent: 0.01 M phosphate buffer, pH 7.4, with 0.13 M NaCl and 15 mM sodium azide
Storage: In the dark at 4-8ºC
Neutrophil gelatinase-associated lipocalin (NGAL; also called lipocalin 2, siderocalin and neutrophil lipocalin) is a member of the lipocalin family of proteins which bind and transport small lipophilic molecules. NGAL is released by activated neutrophils and occurs as 25-kDa glycosylated single protein chain monomers, which form dimers and small amounts of higher oligomers, as well as complexes with matrix metalloproteinase 9 (MMP-9; gelatinase B) (1). Low level expression of NGAL in a variety of epithelia may be increased in inflammation or cancers (2). The expression and release of NGAL from renal tubules are dramatically increased by ischemic or nephrotoxic injury (3).
Human recombinant NGAL in monomer and dimer forms adsorbed to aluminium hydroxide gel (4).
HYB 211-02B is specific for human NGAL and cross-reacts with cynomolgus monkey (Macaca fascicularis) NGAL.
Epitope specificity differs from that of HYB 211-01 and HYB 211-05.
HYB 211-02 reacts strongly with human NGAL. Strong reaction is seen when used as detection antibody in sandwich ELISA in combination with a polyclonal NGAL capture antibody and when tested on recombinant NGAL coated directly onto the well. HYB 211-02 reacts with NGAL in immunochemical staining of paraformaldehyde-fixed sections containing neutrophils. In Western blotting of SDS-PAGE gels, HYB 211-02 reacts with NGAL in both reduced and unreduced forms (4).
HYB 211-02 (as biotinylated detection antibody) forms a sandwich pair with ABS 038-23 (as capture antibody) for measuring cynomolgus monkey (Macaca fascicularis) and human NGAL.
| Method | Usability | Dilution guideline | References |
| ELISA | yes | ||
| Immunoblotting | |||
| Immunohistochemistry |
1. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268:10425-10432.
2. Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L (1996) Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38:414-420.
3. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534-2543.
4. Kjeldsen L, Koch C, Arnljots K, Borregaard N (1996) Characterization of two ELISAs for NGAL, a newly described lipocalin in human neutrophils. J Immunol Methods 198:155-164.
Further examples of use, please consult NGAL reference booklet at www.bioporto.com